Hunter Maritime, which is currently in the process of trying to complete their business combination with NCF Wealth Holdings Limited, announced that they have commenced a tender offer to purchase up to 2,173,750 of its Class A common shares at a purchase price of $10.215 per share. The Tender Offer will expire at 5:00 p.m. New York City time on March 15, 2019, unless extended or terminated.
As a refresher, Hunter is domiciled in the Marshall Islands, but they are also classified as a “Foreign Private Issuer (FPI). As such, an FPI cannot do a vote by proxy, they must do a vote by tender offer, per the FPI rules. However, the amount for the Tender Offer is a little curious. If you recall, at the time of the last Tender Offer to extend their completion deadline to April 23rd (which was offered at $10.125 per share), Hunter stated they would be contributing $0.03 per share for every month needed, starting on November 23rd. Since then, Hunter has contributed an additional $0.09. Hence, this is why they are offering shareholders to Tender at $10.215 ($10.125 + $0.09).
However, what about all the interest? According to our estimates, the current amount per share (including interest) in Hunter’s trust is $10.24. Potentially $10.25 by March 15th, when the Tender offer expires.
As we well know by now, Hunter’s prospectus allows management to use any interest earned for working capital. But by not offering shareholders some of that interest at the time of a Tender….well, that’s what got them into a whole big mess at the first go-around.
Stay tuned.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...